Literature DB >> 21482796

Crystal structure of a covalent intermediate in DNA cleavage and rejoining by Escherichia coli DNA topoisomerase I.

Zhongtao Zhang1, Bokun Cheng, Yuk-Ching Tse-Dinh.   

Abstract

DNA topoisomerases control DNA topology by breaking and rejoining DNA strands via covalent complexes with cleaved DNA substrate as catalytic intermediates. Here we report the structure of Escherichia coli topoisomerase I catalytic domain (residues 2-695) in covalent complex with a cleaved single-stranded oligonucleotide substrate, refined to 2.3-Å resolution. The enzyme-substrate intermediate formed after strand cleavage was captured due to the presence of the D111N mutation. This structure of the covalent topoisomerase-DNA intermediate, previously elusive for type IA topoisomerases, shows distinct conformational changes from the structure of the enzyme without bound DNA and provides detailed understanding of the covalent catalysis required for strand cleavage to take place. The portion of cleaved DNA 5' to the site of cleavage is anchored tightly with extensive noncovalent protein-DNA interactions as predicted by the "enzyme-bridged" model. Distortion of the scissile strand at the -4 position 5' to the cleavage site allows specific selectivity of a cytosine base in the binding pocket. Many antibacterial and anticancer drugs initiate cell killing by trapping the covalent complexes formed by topoisomerases. We have demonstrated in previous mutagenesis studies that accumulation of the covalent complex of bacterial topoisomerase I is bactericidal. This structure of the covalent intermediate provides the basis for the design of novel antibiotics that can trap the enzyme after formation of the covalent complex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482796      PMCID: PMC3084087          DOI: 10.1073/pnas.1100300108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Overexpression and purification of bacterial DNA topoisomerase I.

Authors:  C X Zhu; Y C Tse-Dinh
Journal:  Methods Mol Biol       Date:  1999

2.  Friction and torque govern the relaxation of DNA supercoils by eukaryotic topoisomerase IB.

Authors:  Daniel A Koster; Vincent Croquette; Cees Dekker; Stewart Shuman; Nynke H Dekker
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

3.  Structural basis for gate-DNA recognition and bending by type IIA topoisomerases.

Authors:  Ken C Dong; James M Berger
Journal:  Nature       Date:  2007-12-20       Impact factor: 49.962

4.  Biochemical characterization of an invariant histidine involved in Escherichia coli DNA topoisomerase I catalysis.

Authors:  Kay Perry; Alfonso Mondragón
Journal:  J Biol Chem       Date:  2002-01-24       Impact factor: 5.157

5.  Structural similarities between topoisomerases that cleave one or both DNA strands.

Authors:  J M Berger; D Fass; J C Wang; S C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

6.  Covalent bonds between protein and DNA. Formation of phosphotyrosine linkage between certain DNA topoisomerases and DNA.

Authors:  Y C Tse; K Kirkegaard; J C Wang
Journal:  J Biol Chem       Date:  1980-06-25       Impact factor: 5.157

7.  Identification of active site residues in Escherichia coli DNA topoisomerase I.

Authors:  S J Chen; J C Wang
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

Review 8.  Hospital-acquired infections due to gram-negative bacteria.

Authors:  Anton Y Peleg; David C Hooper
Journal:  N Engl J Med       Date:  2010-05-13       Impact factor: 91.245

9.  Crystal structure of a complex of a type IA DNA topoisomerase with a single-stranded DNA molecule.

Authors:  A Changela; R J DiGate; A Mondragón
Journal:  Nature       Date:  2001-06-28       Impact factor: 49.962

Review 10.  Recent advances in bacterial topoisomerase inhibitors.

Authors:  Barton J Bradbury; Michael J Pucci
Journal:  Curr Opin Pharmacol       Date:  2008-06-12       Impact factor: 5.547

View more
  33 in total

1.  Synthesis and dissolution of hemicatenanes by type IA DNA topoisomerases.

Authors:  Shun-Hsiao Lee; Grace Ee-Lu Siaw; Smaranda Willcox; Jack D Griffith; Tao-Shih Hsieh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-03       Impact factor: 11.205

2.  Identification of proximal sites for unwound DNA substrate in Escherichia coli topoisomerase I with oxidative crosslinking.

Authors:  Bokun Cheng; Qingxuan Zhou; Liwei Weng; John D Leszyk; Marc M Greenberg; Yuk-Ching Tse-Dinh
Journal:  FEBS Lett       Date:  2016-12-20       Impact factor: 4.124

3.  Biochemical characterization of the topoisomerase domain of Methanopyrus kandleri topoisomerase V.

Authors:  Rakhi Rajan; Amy K Osterman; Alexandra T Gast; Alfonso Mondragón
Journal:  J Biol Chem       Date:  2014-08-18       Impact factor: 5.157

Review 4.  The many lives of type IA topoisomerases.

Authors:  Anna H Bizard; Ian D Hickson
Journal:  J Biol Chem       Date:  2020-04-10       Impact factor: 5.157

Review 5.  Drugging topoisomerases: lessons and challenges.

Authors:  Yves Pommier
Journal:  ACS Chem Biol       Date:  2013-01-04       Impact factor: 5.100

6.  Metal ion and inter-domain interactions as functional networks in E. coli topoisomerase I.

Authors:  Claudia Sissi; Bokun Cheng; Valentina Lombardo; Yuk-Ching Tse-Dinh; Manlio Palumbo
Journal:  Gene       Date:  2013-04-20       Impact factor: 3.688

7.  Insights from the Structure of Mycobacterium tuberculosis Topoisomerase I with a Novel Protein Fold.

Authors:  Kemin Tan; Nan Cao; Bokun Cheng; Andrzej Joachimiak; Yuk-Ching Tse-Dinh
Journal:  J Mol Biol       Date:  2015-12-03       Impact factor: 5.469

8.  Iron inhibits Escherichia coli topoisomerase I activity by targeting the first two zinc-binding sites in the C-terminal domain.

Authors:  Wu Wang; Xiaolu Su; Xiaobing Wang; Juanjuan Yang; Ting Zhang; Maofeng Wang; Rugen Wan; Guoqiang Tan; Jianxin Lu
Journal:  Protein Sci       Date:  2014-09-13       Impact factor: 6.725

9.  Covalent Complex of DNA and Bacterial Topoisomerase: Implications in Antibacterial Drug Development.

Authors:  Purushottam B Tiwari; Prem P Chapagain; Ahmed Seddek; Thirunavukkarasu Annamalai; Aykut Üren; Yuk-Ching Tse-Dinh
Journal:  ChemMedChem       Date:  2020-03-18       Impact factor: 3.466

10.  Small-Molecule Inhibitors Targeting Topoisomerase I as Novel Antituberculosis Agents.

Authors:  Shayna Sandhaus; Thirunavukkarasu Annamalai; Greg Welmaker; Richard A Houghten; Carlos Paz; Pamela K Garcia; Angelo Andres; Gagandeep Narula; Carolina Rodrigues Felix; Sandra Geden; Mandy Netherton; Rashmi Gupta; Kyle H Rohde; Marc A Giulianotti; Yuk-Ching Tse-Dinh
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.